Dyslipidemia and cardiovascular disease risk factors in patients with type 1 diabetes: A single-center experience

Table 2 Characteristics of the study cohort at the last visit

	All, n = 170	Males, n = 86	Females, n = 84	P value
Age in yr	26.3 ± 5.7	26.5 ± 6.0	26.0 ± 5.5	0.540
Diabetes duration in yr	18.2 ± 5.6	18.6 ± 5.5	17.8 ± 5.8	0.375
Duration follow-up in yr	13.7 ± 3.7	14.1 ± 3.6	13.4 ± 3.9	0.222
HbA1c, %	8.0 ± 1.4	8.2 ± 1.6	7.9 ± 1.1	0.164
HbA1c in mmol/L	63.9	66.1	62.8
Smoker, n (%)	13 (7.6)	7 (8.1)	6 (7.1)	0.807
Oral contraceptive use, n (%)			11 (13.1)
Cardiovascular disease risk factors in patients1, n (%)	All, n = 149	Males, n = 74	Females, n = 75
Diabetes only	13 (8.7)	5 (6.8)	8 (10.7)	0.578
+ 1	41 (27.5)	21 (28.4)	20 (26.7)
+ 2	62 (41.6)	28 (37.8)	34 (45.3)
+ 3	27 (18.1)	16 (21.6)	11 (14.7)
+ 4	6 (4.0)	4 (5.4)	2 (2.7)
Cardiovascular disease risk factors in patients, n (%)
Overweight/obesity, n = 158	63/158 (39.9)	32 (40)	31 (39.7)	0.974
Hypertension, n = 152	37 (24.3)	26 (35.1)	11 (14.1)	0.003
Systolic BP > 130 mmHg	28 (18.4)	22 (29.7)	6 (7.7)	< 0.001
Diastolic BP > 80 mmHg	21 (13.8)	16 (21.6)	5 (6.4)	0.007
Dyslipidemia	113 (66.5)	57 (66.3)	56 (66.7)	0.957
LDL-c > 100 mg/dL	83 (48.8)	43 (50.0)	40 (47.6)	0.641
Triglycerides > 150 mg/dL	27 (15.9)	11 (12.7)	16 (19.0)	0.279
HDL-c < 40 mg/dL (males) and < 50 mg/dL (females)	39 (22.9)	15 (17.4)	24 (28.5)	0.099
Statin use2	29 (18.2)	18 (22.5)	11 (13.9)	0.316

Data are expressed as number (percent) or as mean ± standard deviation. P values are between males and females. Significant values are highlighted in bold.

¹Data on cardiovascular disease risk factors were available for 149 patients (74 males, 75 females).

²Data on medications other than insulin (statins) were documented in the medical records of 159 patients (80 males, 79 females). BP: Blood pressure; HbA1c: Hemoglobin A1c; HDL-c; High-density lipoprotein cholesterol; LDL-c; Low-density lipoprotein cholesterol.